Cachexia and asthenia in cancer patients (Q34571829)

3 August 2017

1 reference

title

Cachexia and asthenia in cancer patients (English)

1 reference

3 August 2017

E Bruera

1

1 reference

3 August 2017

C Sweeney

series ordinal

2

1 reference

3 August 2017

publication date

1 November 2000

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

page(s)

138-147

1 reference

Nutrition support in patients with cancer: what do the data really show?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Parental nutrition: is it oncologically logical?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

1 reference

7 January 2021

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Is neurally mediated hypotension an unrecognised cause of chronic fatigue?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Predicting body composition from anthropometry and bioimpedance in marginally undernourished adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

A review of the drug treatment of cachexia associated with cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Induction of adrenal suppression by megestrol acetate in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Is there a role for melatonin in the treatment of neoplastic cachexia?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Effects of the β2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Sustained anabolic effects of long-term androgen administration in men with AIDS wasting

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Effect of growth hormone and protein intake on tumor growth and host cachexia

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(00)50033-4

7 January 2021

10.1016/S1470-2045(00)00033-4

Identifiers

DOI

1 reference

3 August 2017

1 reference